Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Medical and Pediatric Oncology|April 1, 1995
Reversible thrombocytopenia with levamisoleE W Winquist, N J LassamAmerican Journal of Clinical Oncology|January 22, 2002
Nontraumatic osteonecrosis after chemotherapy for testicular cancer: a systematic reviewE W Winquist, G S Bauman, J BaloghMedical and Pediatric Oncology|October 23, 1997
Hypercalcemia and carcinoma of the penisG M Videtic, C T Ago, E W WinquistAmerican Journal of Hematology|June 1, 1993
Reactivation and dissemination of blastomycosis complicating Hodgkin's disease: a case report and review of the literatureE W Winquist, S L Walmsley, N L BerinsteinJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1995
Ketoconazole in the management of paraneoplastic Cushing's syndrome secondary to ectopic adrenocorticotropin productionE W Winquist, J Laskey, M Crump, et al.International Journal of Radiation Oncology, Biology, Physics|October 27, 1998
Postoperative radiotherapy for Stage I/II seminoma: results for 212 patientsG S Bauman, V M Venkatesan, C T Ago, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Gemcitabine plus cisplatin, an active regimen in advanced urothelial cancer: a phase II trial of the National Cancer Institute of Canada Clinical Trials GroupM J Moore, E W Winquist, N Murray, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 15, 2005
Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers: a Princess Margaret Hospital Phase II Consortium studyS J Hotte, A Oza, E W Winquist, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2003
Randomized, double-blind, controlled trial of mitoxantrone/prednisone and clodronate versus mitoxantrone/prednisone and placebo in patients with hormone-refractory prostate cancer and painD S Ernst, I F Tannock, E W Winquist, et al.Current Oncology (Toronto, Ont.)|October 5, 2011
Progression-free survival as a clinical trial endpoint in advanced renal cell carcinomaS J Hotte, G A Bjarnason, D Y C Heng, et al.Pageof 2